(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one NEW

$0.00 1kg

$0.00 5kg

$0.00 10kg

Min. Order1kg
Purity99%
Cas No32384-65-9
Supply Ability500KG
Update time2023-11-01

Hangzhou ICH Biofarm Co., Ltd

1YR

China

Since2006-07-19

Address1306 Block A, Dragon Times Building, 18 Wantang Road, Hangzhou,310013 CHINA

show less show more

Chemical Properties

Product Name	(3R,4S,5R,6R)-3,4,5-tris(triMethylsilyloxy)-6-((triMethylsilyloxy)Methyl)tetrahydro-2H-pyran-2-one
CAS No	32384-65-9
EC-No
Min. Order	1kg
Purity	99%
Supply Ability	500KG
Release date	2023/11/01

- The chemical name of the compound is (3R,4S,5R,6R)-3,4,5-tris(trimethylsilyloxy)-6-((trimethylsilyloxy)methyl)tetrahydro-2H-pyran-2-one .

- The molecular formula is C18H42O6Si4 and the molecular weight is 466.87 g/mol .

- The compound is a colorless to pale yellow oil that is moisture sensitive .

- The boiling point is 417°C and the flash point is 171°C.

- The compound is sparingly soluble in chloroform, slightly soluble in ethyl acetate and methanol.

- The compound is used as an intermediate and raw material for the synthesis of sodium-glucose transporter inhibitors, such as dapagliflozin, empagliflozin and canagliflozin.

- Sodium-glucose transporter inhibitors are a class of drugs that lower blood glucose levels by blocking the reabsorption of glucose in the kidneys. They are used for the treatment of type 2 diabetes mellitus.

Email: pharmchem1@ichemie.com

Tel&Whatsapp:+86-18771921569

show less show more

Company Profile Introduction

Our company specializes in the research, development and production of APIs and pharmaceutical intermediates. At the same time, our core R&D team has more than 20 years of drug R&D experience. Under the support of a good research and development environment and a professional technical team, our company has obtained rich experience and outstanding achievements of new drugs and generic drugs projects. On the one hand, we are focused on the research and development and the optimization of production processes of generic drugs such as anti-viral and anti-malaria. On the other hand, we are also committed to the cooperative development of innovative drugs in the fields of respiratory system and hypoglycemia. We can provide technical support in all key links of drug research and development for drug production and distribution companies.